[Effects on growth hormone secretion of a new somatostatin analogue (SMS 201-995) and nonspecific releasing hormones in patients with acromegaly].
Candrina
R
R
D000172:Acromegaly / Q000188:drug therapy / Q000503:physiopathology*; D000328:Adult; D005260:Female; D013006:Growth Hormone / Q000097:blood / Q000378:metabolism*; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D010906:Pituitary Hormone-Releasing Hormones / Q000494:pharmacology*; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology*; D013997:Time Factors
D010906:Pituitary Hormone-Releasing Hormones; D013973:Thyrotropin-Releasing Hormone; D013006:Growth Hormone; D015282:Octreotide
Effetti sulla secrezione di ormone della crescita di un nuovo analogo della somatostatina (SMS 201-995) e dei releasing hormones non specifici in pazienti acromegalici.